- Home
- CRL vs BEP Comparison
CRL vs BEP Comparison
Compare CRL & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- BEP
- Stock Information
- Founded
- CRL 1947
- BEP 1999
- Country
- CRL United States
- BEP Canada
- Employees
- CRL N/A
- BEP N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- BEP Electric Utilities: Central
- Sector
- CRL Health Care
- BEP Utilities
- Exchange
- CRL Nasdaq
- BEP Nasdaq
- Market Cap
- CRL 8.0B
- BEP 8.7B
- IPO Year
- CRL 2000
- BEP N/A
- Fundamental
- Price
- CRL $178.73
- BEP $28.43
- Analyst Decision
- CRL Buy
- BEP Buy
- Analyst Count
- CRL 15
- BEP 10
- Target Price
- CRL $190.15
- BEP $33.90
- AVG Volume (30 Days)
- CRL 1.1M
- BEP 1.2M
- Earning Date
- CRL 11-05-2025
- BEP 11-05-2025
- Dividend Yield
- CRL N/A
- BEP 5.28%
- EPS Growth
- CRL N/A
- BEP N/A
- EPS
- CRL N/A
- BEP N/A
- Revenue
- CRL $4,023,704,000.00
- BEP $6,300,000,000.00
- Revenue This Year
- CRL N/A
- BEP $17.43
- Revenue Next Year
- CRL $2.43
- BEP $8.13
- P/E Ratio
- CRL N/A
- BEP N/A
- Revenue Growth
- CRL N/A
- BEP 9.24
- 52 Week Low
- CRL $91.86
- BEP $19.29
- 52 Week High
- CRL $203.01
- BEP $32.72
- Technical
- Relative Strength Index (RSI)
- CRL 58.84
- BEP 44.74
- Support Level
- CRL $157.49
- BEP $28.04
- Resistance Level
- CRL $172.39
- BEP $29.21
- Average True Range (ATR)
- CRL 6.13
- BEP 0.54
- MACD
- CRL 0.81
- BEP -0.27
- Stochastic Oscillator
- CRL 98.84
- BEP 11.05
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.